SMEs are key players in the European pharmaceutical research and development landscape. In IHI projects, SMEs act as one key interface between the latest academic discoveries and implementation in industry. ITTM had the honour to contribut to a recent webinar around the question “How IMI projects facilitate the participation and growth of SMEs ?”
The IHI Programme Office Colm Carroll guided the interesting discussions in which Julia Kurps (HYVE), Mathieu Galtier (Owkin) and Andreas Kremer (ITTM) shared their experience.
More information about the event and the slides presented during the discussion can be found here: https://www.ihi.europa.eu/news-events/events/imi-impact-smes-health-data-management-health-it-sectors-event
#event #ihi #ittm #sme